With 28+ stimulant medications for the treatment of ADHD, there are many choices. The good news is there are many options, unfortunately this leads to confusion for the prescriber. A panel of national experts discussed topics on ADHD and I offered information on a basic concept to thoughtful choose medications. ... Read More
Tag: ADHD medication
22
Mar2019
Stimulants for ADHD and risk of psychosis has been a clinical concern but the risk has thought to be quite low. Dr. Goodman's comments about the study can be read here. The recent New England Journal of Medicine study has demonstrated the risk of psychosis with amphetamines is 0.2% and ... Read More
March 22, 2019David W. Goodman, MD
24
Jan2016
In my previous blog, I wrote, in general, about the increasing obstacles set up by insurance companies to restrict psychiatric medications to patients. Today, I'll tell you a specific example of how a medication dosing thoughtful established for a patient was denied despite both clinical and research evidence to support ... Read More
January 24, 2016David W. Goodman, MD
20
Apr2015
In my periodic entries of insurance companies' denial of ADHD medication dosing, I offer you this recent example.
A female in her late 20s treated for ADHD with a combination of Adderall XR and Strattera. Strattera adds a benefit for her executive function not optimized with Adderall XR. I carefully dosed ... Read More
April 20, 2015David W. Goodman, MD
04
Jan2015
Almost everyday insurance companies request pre-authorization for stimulant medication for my patients. While many of these requests are approved, many others are not. One obstacle to approval is stimulant dosing. Insurance companies routinely deny coverage for any stimulant dose that exceeds FDA drug label maximum dose. You might believe this ... Read More
January 4, 2015David W. Goodman, MD
08
Dec2014
Over the years, it has been challenging for psychiatrists to manage the risks of psychiatric medications in patients who considered childbearing, become pregnant, and chose to breastfeed. And while there is some information on many psychiatric medications, there remains little in regards to stimulant medications. Unfortunately, there is no registry ... Read More
December 8, 2014David W. Goodman, MD
26
Nov2014
As time goes on, my patients are increasingly complaining about the loss of medication coverage or no longer affordable medication copays. Well, they are right and here is the proof. The following text was posted today by the American Medical Association with a link to Bloomberg News. Unfortunately, the public ... Read More
November 26, 2014David W. Goodman, MD
18
Nov2014
Sav-Rx reversed its initial denial of my patient's Adderall XR 80 mg daily after receiving my letter of appeal. In my letter, I highlighted the stable effective dose had been prescribed for quite sometime. Their initial reason for denial was a citing that FDA approved max daily dose was 60 ... Read More
November 18, 2014David W. Goodman, MD
15
Sep2014
With each passing day, I encounter an increasing number of obstructions by insurance companies to authorize and provide my patients with their much needed medication. In my last blog, I highlighted Sav-Rx bogus reason to deny my patient the authorization to continue effective medication because of a change in policy ... Read More
September 15, 2014David W. Goodman, MD
10
Sep2014
With an increasing number of adults being nearly diagnosed with ADHD, the expense of ADHD medications for insurance companies has escalated. While the annual prescription increase for childhood ADHD is less than 3%, the ADHD prescription market is growing at approximately 10% per year. As a result of this change, ... Read More
September 10, 2014David W. Goodman, MD